Table: Hisamitsu - 6-MTH group results
Oct 6 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2023 Aug 31, 2022 Feb 29, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 66.98 59.62 132.30
(+12.3 pct) (+1.8 pct) (+3.1 pct)
Operating 8.40 4.91 11.80
(+70.9 pct) (-13.9 pct) (+1.7 pct)
Recurring 11.64 8.87 14.60
(+31.2 pct) (+29.7 pct) (-9.0 pct)
Net 8.42 6.50 10.60
(+29.4 pct) (+30.0 pct) (-9.7 pct)
EPS 108.34 yen 81.58 yen 136.43 yen
EPS Diluted 108.23 yen 81.51 yen
Ann Div 84.50 yen 85.00 yen
-Q2 div 42.50 yen 42.25 yen
-Q4 div 42.25 yen 42.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO